Looking forward to IFSO 2024This year’s 27th IFSO World Congress returns to Australia for the first time since the 11th World Congress in Sydney in 2006. We caught...
No association between suicidal, self-injurious thoughts and actions and GLP-1sThe available evidence does not support a causal association between the Glucagon-Like Peptide-1 receptor agonists (GLP-1) – dulaglutide,...
Latest findings from the IFSO Global Registry Registries offer opportunities to make meaningful comparisons between countries on the demographics, characteristics, operation types and...
Tirzepatide associated with a potential targeted effect on visceral fat and liver fatExploratory analysis from the SURPASS-3 MRI study has shown a significant reduction of both visceral- and liver fat z-scores, and a shift...
CMS' semaglutide coverage expansion could save millions of livesA group of 44 health care and advocacy organizations is urging the Centers for Medicare & Medicaid Services (CMS) to expand coverage and...
Journal Watch 10/4/2024Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Standardisation of OAGB is key to reducing surgical errors and ensuring consistent patient outcomes2 days ago